The latest price target for Constellium (NYSE:CSTM) was reported by UBS on May 5, 2026. The analyst firm set a price target for $38.00 expecting CSTM to rise to within 12 months (a possible 19.84% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for Constellium (NYSE:CSTM) was provided by UBS, and Constellium initiated their buy rating.

The last upgrade for Constellium SE happened on January 13, 2026 when Wells Fargo raised their price target to $25. Wells Fargo previously had an equal-weight for Constellium SE.

The last downgrade for Constellium SE happened on April 30, 2026 when JP Morgan changed their price target from $30 to $34 for Constellium SE.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Constellium, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Constellium was filed on May 5, 2026 so you should expect the next rating to be made available sometime around May 5, 2027.

While ratings are subjective and will change, the latest Constellium (CSTM) rating was a initiated with a price target of $0.00 to $38.00. The current price Constellium (CSTM) is trading at is $31.71, which is within the analyst’s predicted range.